HighPoint Advisor Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,951
Closed -$59.8K 897
2025
Q4
$59.8K Sell
11,951
-133
-1% -$692 ﹤0.01% 1062
2025
Q3
$61.3K Buy
12,084
+1,092
+10% +$4.81K ﹤0.01% 680
2025
Q2
$47.4K Sell
10,992
-790
-7% -$3.9K ﹤0.01% 672
2025
Q1
$64.7K Sell
11,782
-82
-0.7% -$415 ﹤0.01% 644
2024
Q4
$56.4K Sell
11,864
-1,932
-14% -$8.65K ﹤0.01% 663
2024
Q3
$62.2K Sell
13,796
-500
-3% -$2.46K ﹤0.01% 657
2024
Q2
$71K Buy
14,296
+212
+2% +$1.02K ﹤0.01% 597
2024
Q1
$79K Buy
14,084
+1,430
+11% +$5.47K 0.01% 620
2023
Q4
$50K Buy
+12,654
New +$62K ﹤0.01% 624

Other funds holding MPT

HighPoint Advisor Group's MPT Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Medical Properties Trust (MPT) in Q1 2026, closing a stake of 11,951 shares — an estimated $59.8K sold.

HighPoint Advisor Group first reported a position in MPT in Q4 2023 and held it in 9 quarters. The position peaked at $79K in Q1 2024. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • HighPoint Advisor Group reported no remaining Medical Properties Trust position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 11,951 Medical Properties Trust shares in Q1 2026, an estimated $59.8K.
  • HighPoint Advisor Group first reported a position in Medical Properties Trust in Q4 2023 and held it in 9 quarters.
  • HighPoint Advisor Group's Medical Properties Trust position peaked at $79K in Q1 2024.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.